Intensified regimen effective in large B-cell lymphomaOncology UpdateIntensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin and prednisone (R-ACVBP) significantly improves survival in patients with low- to in…

Cancer Research UKAggressive Lymphoma – Intensive Chemotherapy Significantly Improves Survival …Medical News TodayAccording to a study published Online First in The Lancet, younger individuals who suffer with diffuse large B-cell lymphoma who receive…

FDA clears Spectrum to remove bioscan for Zevalin treatmentPharmaceutical Business ReviewSpectrum said with the approval of removing bioscan, patients undergoing treatment with Zevalin will now receive two infusions of rituximab, followed by a 10-minut…

Exposure to rituximab did not affect ofatumumab efficacy in CLLHemOncTodayOfatumumab is active in patients with chronic lymphocytic leukemia refractory to fludarabine regardless of prior treatment with rituximab, according to the results of a phase 2 r…

Biovest Defines Role of BiovaxID(R) Personalized Cancer Vaccine in Journal of …MarketWatch (press release)concludes that BiovaxID offers a non-immunosuppressive alternative or potentially complementary approach to rituximab maintenance or radio-immun…

EBV in RA patient marrow strongly predicts rituximab successProHealthMethods: Blood and bone marrow from 35 RA patients were analysed for CMV, EBV, HSV-1, HSV-2, parvovirus B19 and polyomavirus using real-time PCR before and 3 months after rituximab (R…

Proactive Investors USA & CanadaSpectrum says FDA removes bioscan requirement for Zevalin cancer treatmentProactive Investors USA & CanadaPatients that are now undergoing treatment with Zevalin will get two infusions of cancer drug rituximab followed b…

Support for PennyBelper NewsPenny Wheeler, of Beaurepaire Crescent, who has scleroderma and pulmonary fibrosis, should get rituximab on the health service according to Belper's Conservative MP Pauline Latham. Derbyshire County Primary Care Trust sa…

Forecasted Sales of Biosimilar Monoclonal Antibodies for Oncology Indications …MarketWatch (press release)Biosimilar versions of rituximab (Biogen Idec/Roche/Chugai/Zenyaku Kogyo's Rituxan/MabThera) could be approved as early as 2013 in Europe. T…

Rituximab plus chemotherapy improved survival in mantle cell lymphomaHemOncTodayAdding rituximab to standard chemotherapy results in an improvement in OS among older patients with mantle cell lymphoma, results of an observational study indicated. Altho…